← Back to all treatments
Ozempic Off-label
(semaglutide) · Once weekly injection
Ozempic (semaglutide) is primarily licensed for type 2 diabetes but is widely prescribed off-label for weight management due to its proven appetite-suppressing effects. It contains the same active ingredient as Wegovy.
How It Works
Ozempic works by mimicking GLP-1, a hormone that regulates appetite and food intake. It slows gastric emptying and acts on brain receptors that control hunger, helping reduce calorie intake naturally.
Key Facts
- Average Weight Loss 10–15%
- Frequency Once weekly injection
- Mechanism GLP-1 receptor agonist
Possible Side Effects
- Nausea or Vomiting
- Diarrhoea or Constipation
- Abdominal discomfort
- Low blood sugar (hypoglycaemia)
Eligibility
- BMI of 30 or above
- BMI of 27+ with weight-related comorbidities
- Clinician determines off-label use is appropriate
- Age 18 or over
Treatment Pricing
Monthly Supply
£150.00 – £250.00
(Price varies depending on dosage requirements)
